missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SIGLEC5 Monoclonal Antibody (238023)
Rat Monoclonal Antibody
Brand: Invitrogen™ MA561028
This item is not returnable.
View return policy
Description
Reconstitute at 0.5 mg/mL in sterile PBS.
SIGLEC5 is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. This protein binds equally to alpha2,3-linked and alpha2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. This molecule is expressed by monocytic/myeloid lineage cells. SIGLEC5 is found at high levels in peripheral blood leukocytes, spleen, bone marrow and at lower levels in lymph node, lung, appendix, placenta, pancreas and thymus. It is expressed by monocytes and neutrophils but absent from leukemic cell lines representing early stages of myelomonocytic differentiation.
Specifications
| SIGLEC5 | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with trehalose and no preservative | |
| Q920G3 | |
| Siglecf | |
| Mouse myeloma cell line NS0-derived recombinant mouse Siglec-F, Asp18-Thr437 (predicted). | |
| 500 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG2b |
| Western Blot | |
| 238023 | |
| Unconjugated | |
| Siglecf | |
| CD170; CD33 antigen-like 2; CD33L2; mSiglec-F; OB-binding protein 2; OBBP2; OB-BP2; Obesity-binding protein 2; sialic acid binding Ig like lectin 5; sialic acid binding Ig-like lectin 5; sialic acid binding Ig-like lectin F; sialic acid-binding Ig-like lectin 5; Sialic acid-binding Ig-like lectin F; sialic acid-binding immunoglobulin-like lectin 5; sialic acid-binding lectin Siglec-F; Siglec; SIGLEC5; siglec-5; Siglecf; Siglec-F | |
| Rat | |
| Protein A/G | |
| RUO | |
| 233186 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction